Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4 + T cells through TLR2 activation

Journal of Immunology

Volumn 184, Issue 6, 2010, Pages 2814-2824

  Ding, Jian ^a   Rapista, Aprille ^a   Teleshova, Natalia ^a,d   Mosoyan, Goar ^a   Jarvis, Gary A ^b,c   Klotman, Mary E ^a   Chang, Theresa L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d POPULATION COUNCIL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; LIPOPEPTIDE; PEPTIDYLGLYCAN; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; VIRUS DNA; TLR2 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; EXPOSURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION SENSITIVITY; KINETICS; NEISSERIA GONORRHOEAE; NUCLEAR IMPORT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL TRANSMISSION; T LYMPHOCYTE ACTIVATION; VIRUS ENTRY; VIRUS REPLICATION; ACTIVE TRANSPORT; AMINO ACID SEQUENCE; CELL CULTURE; CELL CYCLE G0 PHASE; CELL LINE; DISEASE TRANSMISSION; DRUG POTENTIATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; VIROLOGY;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; G0 PHASE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NEISSERIA GONORRHOEAE; TOLL-LIKE RECEPTOR 2;

EID: 77951881803     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902125     Document Type: Article

References (87)

1. Hall, H. I., R. Song, P. Rhodes, J. Prejean, Q. An, L. M. Lee, J. Karon, R. Brookmeyer, E. H. Kaplan, M. T. McKenna, et al. 2008. Estimation of HIV incidence in the United States. JAMA 300: 520-529.
2. Cohen, M. S., and W. C. Miller. 1998. Sexually transmitted diseases and human immunodeficiency virus infection: cause, effect, or both? Int. J. Infect. Dis. 3: 1-4.
3. Plummer, F. A., J. N. Simonsen, D. W. Cameron, J. O. Ndinya-Achola, J. K. Kreiss, M. N. Gakinya, P. Waiyaki, M. Cheang, P. Piot, A. R. Ronald, et al. 1991. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163: 233-239.
4. Cameron, D. W., J. N. Simonsen, L. J. D'Costa, A. R. Ronald, G. M. Maitha, M. N. Gakinya, M. Cheang, J. O. Ndinya-Achola, P. Piot, R. C. Brunham, et al. 1989. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 2: 403-407.
5. Ghys, P. D., K. Fransen, M. O. Diallo, V. Ettiègne-Traoré, I. M. Coulibaly, K. M. Yeboué, M. L. Kalish, C. Maurice, J. P. Whitaker, A. E. Greenberg, and M. Laga. 1997. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 11: F85-F93.
6. Kaul, R., J. Kimani, N. J. Nagelkerke, K. Fonck, E. N. Ngugi, F. Keli, K. S. MacDonald, I. W. Maclean, J. J. Bwayo, M. Temmerman, and Kibera HIV Study Group. 2004. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 291: 2555-2562.
7. Corbett, E. L., R. W. Steketee, F. O. ter Kuile, A. S. Latif, A. Kamali, and R. J. Hayes. 2002. HIV-1/AIDS and the control of other infectious diseases in Africa. Lancet 359: 2177-2187.
8. Cohen, M. S., I. F. Hoffman, R. A. Royce, P. Kazembe, J. R. Dyer, C. C. Daly, D. Zimba, P. L. Vernazza, M. Maida, S. A. Fiscus, et al. 1997. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 349: 1868-1873.
9. Chen, A., I. C. Boulton, J. Pongoski, A. Cochrane, and S. D. Gray-Owen. 2003. Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. AIDS 17: 625-628. (Pubitemid 36293117)
10. Levine, W. C., V. Pope, A. Bhoomkar, P. Tambe, J. S. Lewis, A. A. Zaidi, C. E. Farshy, S. Mitchell, and D. F. Talkington. 1998. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177: 167-174.
11. Klotman, M. E., A. Rapista, N. Teleshova, A. Micsenyi, G. A. Jarvis, W. Lu, E. Porter, and T. L. Chang. 2008. Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J. Immunol. 180: 6176-6185.
12. Zhang, J., G. Li, A. Bafica, M. Pantelic, P. Zhang, H. Broxmeyer, Y. Liu, L. Wetzler, J. J. He, and T. Chen. 2005. Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1. J. Immunol. 174: 7995-8002. (Pubitemid 40806310)
13. Palm, N. W., and R. Medzhitov. 2009. Pattern recognition receptors and control of adaptive immunity. Immunol. Rev. 227: 221-233.
14. Takeuchi, O., and S. Akira. 2009. Innate immunity to virus infection. Immunol. Rev. 227: 75-86.
15. Equils, O., M. L. Schito, H. Karahashi, Z. Madak, A. Yarali, K. S. Michelsen, A. Sher, and M. Arditi. 2003. Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J. Immunol. 170: 5159-5164. (Pubitemid 36554748)
16. Scheller, C., A. Ullrich, K. McPherson, B. Hefele, J. Knöferle, S. Lamla, A. R. Olbrich, H. Stocker, K. Arasteh, V. ter Meulen, et al. 2004. CpG oligodeoxynucleotides activate HIV replication in latently infected human T cells. J. Biol. Chem. 279: 21897-21902.
17. Sundstrom, J. B., D. M. Little, F. Villinger, J. E. Ellis, and A. A. Ansari. 2004. Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol. 172: 4391-4401.
18. Wang, Y., K. Abel, K. Lantz, A. M. Krieg, M. B. McChesney, and C. J. Miller. 2005. The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques. J. Virol. 79: 14355-14370. (Pubitemid 41552733)
19. Liu, X., A. Mosoian, T. Li-Yun Chang, B. Zerhouni-Layachi, A. Snyder, G. A. Jarvis, and M. E. Klotman. 2006. Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J. Infect. Dis. 194: 751-759.
20. Thibault, S., R. Fromentin, M. R. Tardif, and M. J. Tremblay. 2009. TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 6: 42.
21. Thibault, S., M. R. Tardif, C. Barat, and M. J. Tremblay. 2007. TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J. Immunol. 179: 4357-4366.
22. Ogawa, Y., T. Kawamura, T. Kimura, M. Ito, A. Blauvelt, and S. Shimada. 2009. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood 113: 5157-5166.
23. Báfica, A., C. A. Scanga, M. Schito, D. Chaussabel, and A. Sher. 2004. Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors. J. Immunol. 172: 7229-7234. (Pubitemid 38747580)
24. Equils, O., K. K. Salehi, R. Cornataeanu, D. Lu, S. Singh, K. Whittaker, and G. C. Baldwin. 2006. Repeated lipopolysaccharide (LPS) exposure inhibits HIV replication in primary human macrophages. Microbes Infect. 8: 2469-2476. (Pubitemid 44515147)
25. Simard, S., E. Maurais, C. Gilbert, and M. J. Tremblay. 2008. LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons. Clin. Immunol. 127: 198-205.
26. Juffermans, N. P., W. A. Paxton, P. E. Dekkers, A. Verbon, E. de Jonge, P. Speelman, S. J. van Deventer, and T. van der Poll. 2000. Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines. Blood 96: 2649-2654.
27. Moriuchi, M., H. Moriuchi, W. Turner, and A. S. Fauci. 1998. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. J. Clin. Invest. 102: 1540-1550.
28. Báfica, A., C. A. Scanga, M. L. Schito, S. Hieny, and A. Sher. 2003. Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2. J. Immunol. 171: 1123-1127. (Pubitemid 36900038)
29. Cummins, J. E., Jr., and G. F. Doncel. 2009. Biomarkers of cervicovaginal inflammation for the assessment of microbicide safety. Sex. Transm. Dis. 36(3, Suppl)S84-S91.
30. Pridmore, A. C., G. A. Jarvis, C. M. John, D. L. Jack, S. K. Dower, and R. C. Read. 2003. Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains. Infect. Immun. 71: 3901-3908.
31. Massari, P., P. Henneke, Y. Ho, E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537. (Pubitemid 34135744)
32. Zhang, Z., T. Schuler, M. Zupancic, S. Wietgrefe, K. A. Staskus, K. A. Reimann, T. A. Reinhart, M. Rogan, W. Cavert, C. J. Miller, et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
33. Griffiss, J. M., C. J. Lammel, J. Wang, N. P. Dekker, and G. F. Brooks. 1999. Neisseria gonorrhoeae coordinately uses Pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect. Immun. 67: 3469-3480.
34. Chen, B. K., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68: 654-660.
35. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-1 - infected individuals. J. Exp. Med. 185: 621-628.
36. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61: 213-222. (Pubitemid 120034987)
37. Zazzi, M., L. Romano, M. Catucci, G. Venturi, A. De Milito, P. Almi, A. Gonnelli, M. Rubino, U. Occhini, and P. E. Valensin. 1997. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J. Med. Virol. 52: 20-25.
38. Cara, A., A. Cereseto, F. Lori, and M. S. Reitz, Jr. 1996. HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA. J. Biol. Chem. 271: 5393-5397.
39. Plant, L. J., and A. B. Jonsson. 2006. Type IV pili of Neisseria gonorrhoeae influence the activation of human CD4+ T cells. Infect. Immun. 74: 442-448.
40. Boulton, I. C., and S. D. Gray-Owen. 2002. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat. Immunol. 3: 229-236.
41. Youssef, A. R., M. van der Flier, S. Estevão, N. G. Hartwig, P. van der Ley, and M. Virji. 2009. Opa+ and Opa- isolates of Neisseria meningitidis and Neisseria gonorrhoeae induce sustained proliferative responses in human CD4+ T cells. Infect. Immun. 77: 5170-5180.
42. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278: 5509-5512.
43. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity 11: 443-451. (Pubitemid 29504199)
44. Fisette, P. L., S. Ram, J. M. Andersen, W. Guo, and R. R. Ingalls. 2003. The Lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-kappaB activation in epithelial cells in a Toll-like receptor 2-dependent manner. J. Biol. Chem. 278: 46252-46260.
45. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392-5396.
46. Ozinsky, A., D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
47. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P. F. Mühlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887-5894. (Pubitemid 33062783)
48. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
49. Farhat, K., S. Riekenberg, H. Heine, J. Debarry, R. Lang, J. Mages, U. Buwitt-Beckmann, K. Röschmann, G. Jung, K. H. Wiesmüller, and A. J. Ulmer. 2008. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J. Leukoc. Biol. 83: 692-701.
50. Gutierrez, O., C. Pipaon, N. Inohara, A. Fontalba, Y. Ogura, F. Prosper, G. Nunez, and J. L. Fernandez-Luna. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277: 41701-41705.
51. Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdörfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531-4537. (Pubitemid 34441357)
52. Smith, K. A. 1988. Interleukin-2: inception, impact, and implications. Science 240: 1169-1176.
53. Miyazaki, T., Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada, Y. Tsujimoto, E. L. Barsoumian, R. M. Permutter, and T. Taniguchi. 1995. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231.
54. Imanishi, T., H. Hara, S. Suzuki, N. Suzuki, S. Akira, and T. Saito. 2007. Cutting edge: TLR2 directly triggers Th1 effector functions. J. Immunol. 178: 6715-6719. (Pubitemid 46847393)
55. Bukrinsky, M. I., N. Sharova, M. P. Dempsey, T. L. Stanwick, A. G. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89: 6580-6584.
56. Plesa, G., J. Dai, C. Baytop, J. L. Riley, C. H. June, and U. O'Doherty. 2007. Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells. J. Virol. 81: 13938-13942.
57. Heine, H., S. Müller-Loennies, L. Brade, B. Lindner, and H. Brade. 2003. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur. J. Biochem. 270: 440-450.
58. Bas, S., L. Neff, M. Vuillet, U. Spenato, T. Seya, M. Matsumoto, and C. Gabay. 2008. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol. 180: 1158-1168.
59. Xu, D., M. Komai-Koma, and F. Y. Liew. 2005. Expression and function of Tolllike receptor on T cells. Cell. Immunol. 233: 85-89.
60. Zanin-Zhorov, A., G. Tal-Lapidot, L. Cahalon, M. Cohen-Sfady, M. Pevsner-Fischer, O. Lider, and I. R. Cohen. 2007. Cutting edge: T cells respond to lipopolysaccharide innately via TLR4 signaling. J. Immunol. 179: 41-44. (Pubitemid 46986515)
61. Mares, D., J. A. Simoes, R. M. Novak, and G. T. Spear. 2008. TLR2-mediated cell stimulation in bacterial vaginosis. J. Reprod. Immunol. 77: 91-99.
62. Atashili, J., C. Poole, P. M. Ndumbe, A. A. Adimora, and J. S. Smith. 2008. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493-1501.
63. Hansen, J. K., K. P. Demick, J. M. Mansfield, and K. T. Forest. 2007. Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immuno-suppressive. Infect. Immun. 75: 4138-4147.
64. Aida, Y., and G. Matsuda. 2009. Role of Vpr in HIV-1 nuclear import: therapeutic implications. Curr. HIV Res. 7: 136-143.
65. Piller, S. C., L. Caly, and D. A. Jans. 2003. Nuclear import of the pre-integration complex (PIC): the Achilles heel of HIV? Curr. Drug Targets 4: 409-429.
66. Romani, B., and S. Engelbrecht. 2009. Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. J. Gen. Virol. 90: 1795-1805
67. Sun, Y., L. M. Pinchuk, M. B. Agy, and E. A. Clark. 1997. Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway. J. Immunol. 158: 512-517. (Pubitemid 127483895)
68. Polacino, P. S., H. A. Liang, E. J. Firpo, and E. A. Clark. 1993. T-cell activation influences initial DNA synthesis of simian immunodeficiency virus in resting T lymphocytes from macaques. J. Virol. 67: 7008-7016.
69. Polacino, P. S., L. M. Pinchuk, S. P. Sidorenko, and E. A. Clark. 1996. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25: 201-209.
70. Stevenson, M.,B.Brichacek, N. Heinzinger, S. Swindells, S. Pirruccello, E. Janoff, and M. Emerman. 1995.Molecular basis of cell cycle dependentHIV-1 replication. Implications for control of virus burden. Adv. Exp. Med. Biol. 374: 33-45.
71. Chou, C. S., O. Ramilo, and E. S. Vitetta. 1997. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. Proc. Natl. Acad. Sci. USA 94: 1361-1365.
72. Scales, D., H. Ni, F. Shaheen, J. Capodici, G. Cannon, and D. Weissman. 2001. Nonproliferating bystander CD4+ T cells lacking activation markers support HIV replication during immune activation. J. Immunol. 166: 6437-6443. (Pubitemid 32440779)
73. Zack, J. A., A.M. Haislip, P. Krogstad, and I. S. Chen. 1992. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66: 1717-1725.
74. Blaak, H., A. B. van't Wout, M. Brouwer, B. Hooibrink, E. Hovenkamp, and H. Schuitemaker. 2000. In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline. Proc. Natl. Acad. Sci. USA 97: 1269-1274.
75. Ostrowski, M. A., T. W. Chun, S. J. Justement, I. Motola, M. A. Spinelli, J. Adelsberger, L. A. Ehler, S. B. Mizell, C. W. Hallahan, and A. S. Fauci. 1999. Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J. Virol. 73: 6430-6435.
76. Stremlau, M., C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski. 2004. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853. (Pubitemid 38297747)
77. Bukrinsky, M. I., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254: 423-427.
78. Lassen, K. G., K. X. Ramyar, J. R. Bailey, Y. Zhou, and R. F. Siliciano. 2006. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2: e68.
79. Ganesh, L., E. Burstein, A. Guha-Niyogi, M. K. Louder, J. R. Mascola, L. W. Klomp, C. Wijmenga, C. S. Duckett, and G. J. Nabel. 2003. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes. Nature 426: 853-857. (Pubitemid 38056872)
80. Huang, J., F. Wang, E. Argyris, K. Chen, Z. Liang, H. Tian, W. Huang, K. Squires, G. Verlinghieri, and H. Zhang. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13: 1241-1247.
81. Williams, S. A., and W. C. Greene. 2007. Regulation of HIV-1 latency by T-cell activation. Cytokine 39: 63-74. (Pubitemid 47446257)
82. Pierson, T., J. McArthur, and R. F. Siliciano. 2000. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu. Rev. Immunol. 18: 665-708.
83. Pierson, T. C., Y. Zhou, T. L. Kieffer, C. T. Ruff, C. Buck, and R. F. Siliciano. 2002. Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection. J. Virol. 76: 8518-8531. (Pubitemid 34864046)
84. Mittal, A., S. Rastogi, B. S. Reddy, S. Verma, S. Salhan, and E. Gupta. 2004. Enhanced immunocompetent cells in chlamydial cervicitis. J. Reprod. Med. 49: 671-677.
85. Ficarra, M., J. S. Ibana, C. Poretta, L. Ma, L. Myers, S. N. Taylor, S. Greene, B. Smith, M. Hagensee, D. H. Martin, and A. J. Quayle. 2008. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection. Am. J. Reprod. Immunol. 60: 415-425.
86. Patterson, B. K., M. Czerniewski, J. Andersson, Y. Sullivan, F. Su, D. Jiyamapa, Z. Burki, and A. Landay. 1999. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes. Clin. Immunol. 91: 254-262.
87. Bleul, C. C., L. Wu, J. A. Hoxie, T. A. Springer, and C. R. Mackay. 1997. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94: 1925-1930.